352 related articles for article (PubMed ID: 18679614)
1. Preparation and quantification of pseudotyped retroviral vector.
Yu H; Kwon YJ
Methods Mol Biol; 2008; 433():1-16. PubMed ID: 18679614
[TBL] [Abstract][Full Text] [Related]
2. High efficiency in vitro gene transfer into vascular tissues using a pseudotyped retroviral vector without pseudotransduction.
Yu H; Eton D; Wang Y; Kumar SR; Tang L; Terramani TT; Benedict C; Hung G; Anderson WF
Gene Ther; 1999 Nov; 6(11):1876-83. PubMed ID: 10602383
[TBL] [Abstract][Full Text] [Related]
3. [High efficiency gene transfer into breast cancer cells by pseudotyped retroviral vector].
Tang LL; Yu H
Hunan Yi Ke Da Xue Xue Bao; 2001 Feb; 26(1):48-50. PubMed ID: 12536615
[TBL] [Abstract][Full Text] [Related]
4. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts.
Arai T; Takada M; Ui M; Iba H
Virology; 1999 Jul; 260(1):109-15. PubMed ID: 10405362
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer in human skin with different pseudotyped HIV-based vectors.
Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP
Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532
[TBL] [Abstract][Full Text] [Related]
7. VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection.
Okimoto T; Friedmann T; Miyanohara A
Mol Ther; 2001 Sep; 4(3):232-8. PubMed ID: 11545614
[TBL] [Abstract][Full Text] [Related]
8. Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.
Chen Y; Miller WM; Aiyar A
Biotechnol Prog; 2005; 21(1):274-82. PubMed ID: 15903266
[TBL] [Abstract][Full Text] [Related]
9. Gene delivery to airway epithelial cells in vivo: a direct comparison of apical and basolateral transduction strategies using pseudotyped lentivirus vectors.
Kremer KL; Dunning KR; Parsons DW; Anson DS
J Gene Med; 2007 May; 9(5):362-8. PubMed ID: 17380490
[TBL] [Abstract][Full Text] [Related]
10. Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors.
Barrette S; Douglas J; Orlic D; Anderson SM; Seidel NE; Miller AD; Bodine DM
Mol Ther; 2000 Apr; 1(4):330-8. PubMed ID: 10933951
[TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatographic total particles quantification of retroviral vectors pseudotyped with vesicular stomatitis virus-G glycoprotein.
Transfiguracion J; Coelho H; Kamen A
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):167-73. PubMed ID: 15556530
[TBL] [Abstract][Full Text] [Related]
12. High efficiency and long-term foreign gene expression in cultured liver sinusoidal endothelial cells by retroviral transduction.
Paez J; Montaño R; Benatuil L; Iacomini J; Cardier JE
Endothelium; 2006; 13(4):279-85. PubMed ID: 16990184
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analyses of stability of simple and complex retroviral vectors.
Higashikawa F; Chang L
Virology; 2001 Feb; 280(1):124-31. PubMed ID: 11162826
[TBL] [Abstract][Full Text] [Related]
14. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
Bartz SR; Vodicka MA
Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
[TBL] [Abstract][Full Text] [Related]
15. In vivo gene marking of rhesus macaque long-term repopulating hematopoietic cells using a VSV-G pseudotyped versus amphotropic oncoretroviral vector.
Shi PA; De Angioletti M; Donahue RE; Notaro R; Luzzatto L; Dunbar CE
J Gene Med; 2004 Apr; 6(4):367-73. PubMed ID: 15079811
[TBL] [Abstract][Full Text] [Related]
16. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems.
Swift S; Lorens J; Achacoso P; Nolan GP
Curr Protoc Immunol; 2001 May; Chapter 10():Unit 10.17C. PubMed ID: 18432682
[TBL] [Abstract][Full Text] [Related]
17. Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications.
Farley DC; Iqball S; Smith JC; Miskin JE; Kingsman SM; Mitrophanous KA
J Gene Med; 2007 May; 9(5):345-56. PubMed ID: 17366519
[TBL] [Abstract][Full Text] [Related]
18. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
19. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
20. Production of vesicular stomatitis virus G glycoprotein (VSV-G) pseudotyped retroviral vectors.
Lo HL; Yee JK
Curr Protoc Hum Genet; 2007 Jan; Chapter 12():Unit 12.7. PubMed ID: 18428407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]